1
|
Rodriguez-Granillo AM, Solórzano L, Pérez-Omaña GV, Ascarrunz D, Pavlovsky H, Gomez-Valerio R, Bertrán I, Flores F, Parra J, Guiroy J, Mieres J, Carvajal F, Fernández-Pereira C, Rodriguez AE. Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortium. Front Cardiovasc Med 2024; 11:1275907. [PMID: 38826814 PMCID: PMC11140057 DOI: 10.3389/fcvm.2024.1275907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Accepted: 04/16/2024] [Indexed: 06/04/2024] Open
Abstract
Background ST-elevation myocardial infarction (STEMI) requires revascularization treatment, preferably via primary percutaneous coronary interventions (pPCI). There is a lack of data about contemporary management of STEMI in Latin America. Methods This was a multicenter, multinational, prospective, and dynamic registry of patients undergoing pPCI in Latin America for STEMI (STEMI/LATAMI Registry) that was carried out in nine centers from five countries (Argentina, Ecuador, Venezuela, Bolivia, and the Dominican Republic) between June 2021 and June 2023. All interventionalists involved in the study were originally trained at the same institution (Centro de Estudios en Cardiología Intervencionista, Buenos Aires, Argentina). The primary objective was to evaluate procedural and in-hospital outcomes of pPCI in STEMI and in-hospital outcome in the Latin America (LATAM) region; as secondary endpoints, we analyzed the following subgroups: differences between pPCI vs. pharmaco-invasive or late presenters, gender, elderly and very elderly patients, cardiogenic shock outcomes, and causes of STEMI. Results In total, 744 STEMI patients who underwent PCI between June 2021 and June 2023 in five countries (nine centers) in our continent were included; 76.3% had a pPCI, 8.1% pharmaco-invasive PCI, and 15.6% had late STEMI PCI. There were no differences in region or center when we evaluated in-hospital and 30 days of death. The rate of procedural success was 96.2%, and the overall in-hospital mortality rate was 2.2%. In the subgroup of pPCI, mean symptom onset-to-balloon time was 295.3 ± 246 min, and mean door-to-balloon time was 55.8 ± 49.9 min. The femoral approach was chosen in 60.5%. In 3.0% of patients, the left main disease was the culprit artery, with 1.63 ± 1.00 stents per patient (564 drug-eluting stents and 652 bare metal stents), with 34 patients receiving only plain optimal balloon angioplasty. Definitive stent thrombosis was related to the infarct artery as the primary cause of STEMI in 7.5% of patients. The use of assistant mechanical devices was low, at 2.1% in the pPCI group. Women were older, with large numbers in very elderly age (≥90 years), greater mortality, and incidence of spontaneous coronary dissection as a cause of STEMI (p < 0.001, p < 0.001, p < 0.001, and p < 0.003, respectively). Conclusion In suitable LATAM Centers from low/medium-income countries, this prospective registry in patients with STEMI, PCI performed by well-trained operators has comparable results to those reported in well-developed countries.
Collapse
Affiliation(s)
- Alfredo Matías Rodriguez-Granillo
- Interventional Cardiology Department, Centro de Estudios en Cardiología Intervencionista (CECI), Ciudad de Buenos Aires, Argentina
- Interventional Cardiology Department, Sanatorio Las Lomas, San Isidro, Provincia de Buenos Aires, Argentina
| | - Leonardo Solórzano
- Interventional Cardiology Department, CardioCentro, Manta, Manabí, Ecuador
| | | | - Diego Ascarrunz
- Interventional Cardiology Department, Sanatorio Las Lomas, San Isidro, Provincia de Buenos Aires, Argentina
- Interventional Cardiology Department, Clínica IMA, Adrogué, Provincia de Buenos Aires, Argentina
| | - Hernán Pavlovsky
- Interventional Cardiology Department, Sanatorio Las Lomas, San Isidro, Provincia de Buenos Aires, Argentina
- Interventional Cardiology Department, Clínica IMA, Adrogué, Provincia de Buenos Aires, Argentina
| | - Reynaldo Gomez-Valerio
- Interventional Cardiology Department, Centro de Intervenciones Cardiovasculares, Santo Domingo, Dominican Republic
| | - Ignacio Bertrán
- Interventional Cardiology Department, Sanatorio Otamendi, Ciudad de Buenos Aires, Argentina
| | - Federico Flores
- Interventional Cardiology Department, Sanatorio Otamendi, Ciudad de Buenos Aires, Argentina
| | - Julio Parra
- Interventional Cardiology Department, InCorazón, Quito, Ecuador
| | - Juan Guiroy
- Interventional Cardiology Department, Instituto Cardiovascular del Chaco, Resistencia, Provincia de Chaco, Argentina
| | - Juan Mieres
- Interventional Cardiology Department, Centro de Estudios en Cardiología Intervencionista (CECI), Ciudad de Buenos Aires, Argentina
- Interventional Cardiology Department, Sanatorio Las Lomas, San Isidro, Provincia de Buenos Aires, Argentina
- Interventional Cardiology Department, Sanatorio Otamendi, Ciudad de Buenos Aires, Argentina
| | - Francisco Carvajal
- Interventional Cardiology Department, Sanatorio Las Lomas, San Isidro, Provincia de Buenos Aires, Argentina
- Interventional Cardiology Department, InCorazón, Quito, Ecuador
| | - Carlos Fernández-Pereira
- Interventional Cardiology Department, Centro de Estudios en Cardiología Intervencionista (CECI), Ciudad de Buenos Aires, Argentina
- Interventional Cardiology Department, Clínica IMA, Adrogué, Provincia de Buenos Aires, Argentina
- Interventional Cardiology Department, Sanatorio Otamendi, Ciudad de Buenos Aires, Argentina
| | - Alfredo E. Rodriguez
- Interventional Cardiology Department, Centro de Estudios en Cardiología Intervencionista (CECI), Ciudad de Buenos Aires, Argentina
- Interventional Cardiology Department, Sanatorio Las Lomas, San Isidro, Provincia de Buenos Aires, Argentina
- Interventional Cardiology Department, Sanatorio Otamendi, Ciudad de Buenos Aires, Argentina
| |
Collapse
|
2
|
Arias-Mendoza A, Gopar-Nieto R, Juarez-Tolen J, Ordóñez-Olvera JC, Gonzalez-Pacheco H, Briseño-De la Cruz JL, Sierra-Lara Martinez D, Mendoza-García S, Altamirano-Castillo A, Montañez-Orozco A, Arzate-Ramirez A, Baeza-Herrera LA, Ortega-Hernandez JA, Miranda-Cerda G, Cruz-Martinez JE, Baranda-Tovar FM, Zabal-Cerdeira C, Araiza-Garaygordobil D. Long-Term Outcomes of Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study from Mexico City. Am J Cardiol 2024; 218:7-15. [PMID: 38402926 DOI: 10.1016/j.amjcard.2024.02.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 01/08/2024] [Accepted: 02/04/2024] [Indexed: 02/27/2024]
Abstract
Although primary percutaneous coronary intervention (pPCI) is the treatment of choice in ST-elevation myocardial infarction (STEMI), challenges may arise in accessing this intervention for certain geodemographic groups. Pharmacoinvasive strategy (PIs) has demonstrated comparable outcomes when delays in pPCI are anticipated, but real-world data on long-term outcomes are limited. The aim of the present study was to compare long-term outcomes among real-world patients with STEMI who underwent either PIs or pPCI. This was a prospective registry including patients with STEMI who received reperfusion during the first 12 hours from symptom onset. The primary objective was cardiovascular mortality at 12 months according to the reperfusion strategy (pPCI vs PIs) and major cardiovascular events (cardiogenic shock, recurrent myocardial infarction, and congestive heart failure), and Bleeding Academic Research Consortium type 3 to 5 bleeding events were also evaluated. A total of 799 patients with STEMI were included; 49.1% underwent pPCI and 50.9% received PIs. Patients in the PIs group presented with more heart failure on admission (Killip-Kimbal >I 48.1 vs 39.7, p = 0.02) and had a lower proportion of pre-existing heart failure (0.2% vs 1.8%, p = 0.02) and atrial fibrillation (0.25% vs 1.2%, p = 0.02). No statistically significant difference was observed in cardiovascular mortality at the 12-month follow-up (hazard ratio for PIs 0.74, 95% confidence interval 0.42 to 1.30, log-rank p = 0.30) according to the reperfusion strategy used. The composite of major cardiovascular events (hazard ratio for PIs 0.98, 95% confidence interval 0.75 to 1.29, p = 0.92) and Bleeding Academic Research Consortium type 3 to 5 bleeding rates were also comparable. A low socioeconomic status, Killip-Kimball >2, age >60 years, and admission creatinine >2.0 mg/100 ml were predictors of the composite end point after multivariate analysis. In conclusion, this prospective real-world registry provides additional support that long-term major cardiovascular outcomes and bleeding are not different between patients who underwent PIs versus primary PCI.
Collapse
Affiliation(s)
- Alexandra Arias-Mendoza
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Rodrigo Gopar-Nieto
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Jessica Juarez-Tolen
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Juan Carlos Ordóñez-Olvera
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Héctor Gonzalez-Pacheco
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Jose Luis Briseño-De la Cruz
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Daniel Sierra-Lara Martinez
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Salvador Mendoza-García
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Alfredo Altamirano-Castillo
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Alvaro Montañez-Orozco
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Arturo Arzate-Ramirez
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Luis A Baeza-Herrera
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Jorge A Ortega-Hernandez
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Greta Miranda-Cerda
- Emergency department, Hospital General Dr. Manuel Gea González, Ciudad de México, México City
| | | | | | - Carlos Zabal-Cerdeira
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City
| | - Diego Araiza-Garaygordobil
- Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México City.
| |
Collapse
|
3
|
Luo Z, Feng Y, Luo D, Li S, Xiao K, Shen H, Hu Q. Favorable factors for the survival of ST-segment elevation myocardial infarction patients with medium- and high-risk thrombolysis in myocardial infarction scores. BMC Cardiovasc Disord 2023; 23:614. [PMID: 38093222 PMCID: PMC10720153 DOI: 10.1186/s12872-023-03628-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Accepted: 11/21/2023] [Indexed: 12/17/2023] Open
Abstract
OBJECTIVE ST-segment myocardial infarction (STEMI) is a time-sensitive emergency. This study screened the favorable factors for the survival of STEMI patients with medium- and high-risk thrombolysis in myocardial infarction (TIMI) scores. METHODS According to the TIMI scores at admission, 433 STEMI patients were retrospectively and consecutively selected and allocated into low-/medium-/high-risk groups, with their general information/blood routine/biochemical indicators/coagulation indicators documented. The factors influencing the in-hospital survival of STEMI patients were analyzed using univariate and multivariate logistic regression analyses. Moreover, the predictive value of favorable factors was analyzed by receiver operating characteristics (ROC) curve, and patients were assigned into high/low level groups based on the cut-off value of these factors, with their in-hospital survival rates compared. RESULTS The in-hospital survival rate of the medium-/high-risk groups was lower than that of the low-risk group. Emergency percutaneous coronary intervention (PCI), lymphocyte (LYM), total protein (TP), albumin (ALB), and sodium (Na) were independent favorable factors for in-hospital survival in the medium-/high-risk groups. Besides, LYM > 1.275 × 109/L, TP > 60.25 g/L, ALB > 34.55 g/L, and Na > 137.9 mmo1/L had auxiliary predictive value for the survival of STEMI patients with medium-/high-risk TIMI scores. Patients with high levels of LYM, TP, ALB, and Na exhibited higher in-hospital survival rates than patients with low levels. CONCLUSION For STEMI patients with medium- and high-risk TIMI scores, accepting emergency PCI and normal levels of LYM, TP, ALB, and Na were more conducive to in-hospital survival.
Collapse
Affiliation(s)
- Zhengli Luo
- Emergency Department, Panzhihua Central Hospital, No. 34 Yikang Street, Middle Section of Panzhihua Avenue, Panzhihua, 617000, China
| | - Yuan Feng
- Emergency Department, Panzhihua Central Hospital, No. 34 Yikang Street, Middle Section of Panzhihua Avenue, Panzhihua, 617000, China
| | - Dan Luo
- Emergency Department, Panzhihua Central Hospital, No. 34 Yikang Street, Middle Section of Panzhihua Avenue, Panzhihua, 617000, China
| | - Shiyang Li
- Division of Cardiology, Panzhihua Central Hospital, Panzhihua, China
| | - Kaiyi Xiao
- Emergency Department, Panzhihua Central Hospital, No. 34 Yikang Street, Middle Section of Panzhihua Avenue, Panzhihua, 617000, China
| | - Hongmei Shen
- Information Center, Panzhihua Central Hospital, Panzhihua, China
| | - Qiang Hu
- Emergency Department, Panzhihua Central Hospital, No. 34 Yikang Street, Middle Section of Panzhihua Avenue, Panzhihua, 617000, China.
| |
Collapse
|
4
|
Wang Z, Peng J. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention. Sci Rep 2023; 13:5084. [PMID: 36977721 PMCID: PMC10050001 DOI: 10.1038/s41598-023-32222-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2023] [Accepted: 03/24/2023] [Indexed: 03/30/2023] Open
Abstract
Ischemia-reperfusion injury is a risk factor for poor clinical prognosis in patients with ST-segment elevation myocardial infarction (STEMI). However, due to the inability to predict the risk of its occurrence early, the effect of intervention measures is still being determined. This study intends to construct a nomogram prediction model and evaluate its value in predicting the risk of ischemia-reperfusion injury (IRI) after primary percutaneous coronary intervention (PCI). The clinical admission data of 386 STEMI patients who underwent primary PCI were retrospectively analyzed. According to the degree of ST-segment resolution (STR), the patients were divided into the STR < 70% group (n = 197) and the STR > 70 group (n = 187). The least absolute shrinkage and selection operator (LASSO) regression method was used to screen out IRI's admission-related clinical risk factors. The R language software was used to construct and verify the IRI nomogram prediction model based on the above indicators. The peak troponin level and the incidence of in-hospital death in the STR < 70% group were significantly higher than those in the STR > 70% group (p < 0.01), and the left ventricular ejection fraction was significantly lower than that in the STR > 70% group (p < 0.01). Combined with the results of LASSO regression and receiver operating characteristic curve comparison analysis, we constructed a six-dimensional nomogram predictive model: hypertension, anterior myocardial infarction, culprit vessel, proximal occlusion, C-reactive protein (CRP) > 3.85 mg/L, white blood cell count, neutrophil cell count, and lymphocyte count. The area under the nomogram's receiver operating characteristic (ROC) curve was 0.779. The clinical decision curve found that the nomogram had good clinical applicability when the occurrence probability of IRI was between 0.23 and 0.95. The nomogram prediction model constructed based on six clinical factors at admission has good prediction efficiency and clinical applicability regarding the risk of IRI after primary PCI in patients with acute myocardial infarction.
Collapse
Affiliation(s)
- Zuoyan Wang
- Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Haidian District, Beijing, 100038, China
| | - Jianjun Peng
- Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Haidian District, Beijing, 100038, China.
| |
Collapse
|
5
|
Zhang D, Wu H, Liu D, Li Y, Zhou G, Yang Q, Liu Y. Clinical efficacy of sacubitril-valsartan combined with acute ST-segment elevation myocardial infarction after reperfusion: A systematic review and meta-analysis. Front Cardiovasc Med 2022; 9:1036151. [PMID: 36531731 PMCID: PMC9751057 DOI: 10.3389/fcvm.2022.1036151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2022] [Accepted: 11/14/2022] [Indexed: 11/03/2023] Open
Abstract
Background Several studies have investigated the combined use of sacubitril- valsartan after reperfusion in acute ST-segment elevation myocardial infarction (STEMI). However, the sample sizes of these studies were small and their results were somewhat heterogeneous. To determine the effect of sacubitril-valsartan on myocardial ischemia-reperfusion. Methods Search PubMed, EMbase, Web of Science and The Cochrane Library, CNKI database, VIP database and Wanfang digital journal full-text database for eligible articles from their date of inception up to April, 2022. All data were meta-analyzed using Review Manager 5.3 and STATA 16.0 software. Results A total of 23 studies including 2,326 patients with acute STEMI were included. These results of this meta-analysis indicated that left ventricular ejection fractions (LVEF) value within 6 months after surgery (OR, 4.29; 95% confidence interval, 3.78-4.80; P < 0.00001), left ventricular end-diastolic diameter (LVEDD) value within 6 months after surgery (OR, -3.11; 95% CI, -3.87 to -2.35; P < 0.00001) and left ventricular end-diastolic volume (LVEDV) value 6 months after operation (OR, -6.22; 95% CI, -7.10 to -5.35; P < 0.00001) are better than without sacubitril and valsartan. Conclusion To sum up the above, the results of this study suggest that sacubitril- valsartan can reduce the reperfusion injury of ischemic myocardium by improving cardiac function within a follow-up period of 6 months.
Collapse
Affiliation(s)
- Dong Zhang
- Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China
- Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China
| | - Hui Wu
- Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China
- Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China
| | - Di Liu
- Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China
- Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China
| | - Yunzhao Li
- Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China
- Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China
| | - Gang Zhou
- Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China
- Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China
| | - QingZhuo Yang
- Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China
- Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China
| | - YanFang Liu
- Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China
- Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China
| |
Collapse
|